Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sage/Biogen Zuranolone Study Shows More Efficacy, But Higher Toxicity
Commercial Prospects Still Murky
Dec 01 2021
•
By
Alaric DeArment
Sage/Biogen released new data from the 50mg cohort of the SHORELINE study of zuranolone • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Neurological
More from Therapeutic Category